Integrin-targeted paclitaxel nanoliposomes for tumor therapy (original) (raw)
Saloustros E, Mavroudis D, Georgoulias V. Paclitaxel and docetaxel in the treatment of breast cancer. Expert Opin Pharmacother. 2008;9(15):2603–16. ArticlePubMedCAS Google Scholar
Greco FA. Paclitaxel-based combination chemotherapy in advanced non-small cell lung cancer. Lung Cancer. 2001;34(Suppl 4):S53–6. ArticlePubMed Google Scholar
Weiss RB, Donehower RC, Wiernik PH, et al. Hypersensitivity reactions from taxol. J Clin Oncol. 1990;8(7):1263–8. PubMedCAS Google Scholar
Hennenfent KL, Govindan R. Novel formulations of taxanes: a review. Old wine in a new bottle? Ann Oncol. 2006;17(5):735–49. ArticlePubMedCAS Google Scholar
Waugh WN, Trissel LA, Stella VJ. Stability, compatibility, and plasticizer extraction of taxol (NSC-125973) injection diluted in infusion solutions and stored in various containers. Am J Hosp Pharm. 1991;48(7):1520–4. PubMedCAS Google Scholar
Treat J, Damjanov N, Huang C, et al. Liposomal-encapsulated chemotherapy: preliminary results of a phase I study of a novel liposomal paclitaxel. Oncology (Williston Park). 2001;15(5 Suppl 7):44–8. CAS Google Scholar
Pasqualini R, Arap W, McDonald DM. Probing the structural and molecular diversity of tumor vasculature. Trends Mol Med. 2002;8(12):563–71. ArticlePubMedCAS Google Scholar
Temming K, Schiffelers RM, Molema G, et al. RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature. Drug Resist Updat. 2005;8(6):381–402. ArticlePubMedCAS Google Scholar
Garanger E, Boturyn D, Dumy P. Tumor targeting with RGD peptide ligands-design of new molecular conjugates for imaging and therapy of cancers. Anticancer Agents Med Chem. 2007;7(5):552–8. PubMedCAS Google Scholar
Holig P, Bach M, Volkel T, et al. Novel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cells. Protein Eng Des Sel. 2004;17(5):433–41. ArticlePubMed Google Scholar
Dubey PK, Mishra V, Jain S, et al. Liposomes modified with cyclic RGD peptide for tumor targeting. J Drug Target. 2004;12(5):257–64. ArticlePubMedCAS Google Scholar
Ceruti M, Crosasso P, Brusa P, et al. Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing water-soluble prodrugs of paclitaxel. J Control Release. 2000;63(1–2):141–53. ArticlePubMedCAS Google Scholar
Stevens PJ, Sekido M, Lee RJ. A folate receptor-targeted lipid nanoparticle formulation for a lipophilic paclitaxel prodrug. Pharm Res. 2004;21(12):2153–7. ArticlePubMedCAS Google Scholar
Smolej L, Kasparova P. Choice of endothelial marker is crucial for assessment of bone marrow microvessel density in chronic lymphocytic leukemia. APMIS. 2008;116(12):1058–62. ArticlePubMedCAS Google Scholar
Singh R, Lillard JW Jr. Nanoparticle-based targeted drug delivery. Exp Mol Pathol. 2009;86(3):215–23. ArticlePubMedCAS Google Scholar
Haley B, Frenkel E. Nanoparticles for drug delivery in cancer treatment. Urol Oncol. 2008;26(1):57–64. ArticlePubMedCAS Google Scholar
Byrne JD, Betancourt T, Brannon-Peppas L. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv Drug Deliv Rev. 2008;60(15):1615–26. ArticlePubMedCAS Google Scholar
Kluza E, van der Schaft DW, Hautvast PA, et al. Synergistic targeting of alphavbeta3 integrin and galectin-1 with heteromultivalent paramagnetic liposomes for combined MR imaging and treatment of angiogenesis. Nano Lett. 2010;10(1):52–8. ArticlePubMedCAS Google Scholar
Yang T, Choi MK, Cui FD, et al. Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome. J Control Release. 2007;120(3):169–77. ArticlePubMedCAS Google Scholar
Shiue L, Green J, Green OM, et al. Interaction of p72syk with the gamma and beta subunits of the high-affinity receptor for immunoglobulin E, Fc epsilon RI. Mol Cell Biol. 1995;15(1):272–81. PubMedCAS Google Scholar
Cui ZK, Bastiat G, Jin C, et al. Influence of the nature of the sterol on the behavior of palmitic acid/sterol mixtures and their derived liposomes. Biochim Biophys Acta. 2010;1798(6):1144–52. ArticlePubMedCAS Google Scholar
Yang T, Cui FD, Choi MK, et al. Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation. Int J Pharm. 2007;338(1–2):317–26. ArticlePubMedCAS Google Scholar
Oku N. Delivery of contrast agents for positron emission tomography imaging by liposomes. Adv Drug Deliv Rev. 1999;37(1–3):53–61. ArticlePubMedCAS Google Scholar